Electromedical Technologies Changes Certifying Accountant

TL;DR

Electromedical Tech swapped accountants, filing 8-K on 5/21/24.

AI Summary

Electromedical Technologies, Inc. filed an 8-K on May 21, 2024, reporting a change in its certifying accountant. The company's previous accountant was removed, and a new one has been appointed. This filing also includes financial statements and exhibits.

Why It Matters

A change in a company's auditor can signal potential issues with financial reporting or a strategic shift in how the company presents its financials.

Risk Assessment

Risk Level: medium — Changes in certifying accountants can sometimes precede or indicate underlying financial reporting concerns.

Key Players & Entities

• Electromedical Technologies, Inc. (company) — Registrant
• May 17, 2024 (date) — Earliest event reported
• May 21, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Scottsdale, AZ (location) — Principal Executive Offices

FAQ

Filing Documents

• tm2415019d1_8k.htm (8-K) — 26KB
• tm2415019d1_ex16-1.htm (EX-16.1) — 3KB
• 0001104659-24-063695.txt ( ) — 201KB
• elcq-20240517.xsd (EX-101.SCH) — 3KB
• elcq-20240517_lab.xml (EX-101.LAB) — 33KB
• elcq-20240517_pre.xml (EX-101.PRE) — 22KB
• tm2415019d1_8k_htm.xml (XML) — 4KB

01 Changes in Registrant's Certifying

Item 4.01 Changes in Registrant's Certifying Accountant. On May 17, 2024, dbbmckennon declined to stand for reelection as the Registrant's independent registered public accounting firm to audit the Registrant's financial statements. dbbmckennon's reports on the Registrant's financial statements for the past two years, which contained an explanatory paragraph regarding the Company's ability to continue as a going concern as a result of recurring losses and working capital deficit, did not contain an adverse opinion or a disclaimer of opinion, or was qualified or modified as to uncertainty, audit scope, or matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures, which disagreements, if not resolved to the satisfaction of dbbmckennon, would have caused dbbmckennon to make reference to such disagreement in its report. The dismissal of dbbmckennon was approved by the Registrant's board of directors. During the two most recent fiscal years, and any subsequent interim period through the date of dismissal, there have been no disagreements with dbbmckennon or certain other reportable events. Pursuant to Item 304(a)(3) of Reg. SK, prior to this filing the Registrant provided dbbmckennon with a copy of its disclosures and requested dbbmckennon to provide the Registrant with a letter addressed to the Commission indicating whether it agrees with the Registrant's disclosures. The Registrant will file an amendment to this Form 8-K upon receipt of the letter from dbbmckennon. (b) On May 17, 2024, the Registrant engaged Hudgens, CPA, PLLC ("Hudgens") as its principal accountant to audit the Registrant's financial statements. During the Registrant's two most recent fiscal years, and any subsequent interim period prior to engaging Hudgens, neither the Registrant nor anyone acting on its behalf consulted with Hudgens regarding (i) either the application of any accounting principles to a specific completed or contemplated transacti

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibit No. Document Location 16.1 Letter from dbbmckennon dated May 21, 2024, to the Securities and Exchange Commission. Filed herewith 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated May 21, 2024 ELECTROMEDICAL TECHNOLOGIES, INC. (Registrant) By: /s/ Matthew Wolfson Matthew Wolfson Principal Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR